These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8360440)

  • 1. [The use of sulprostone (Nalador) in the evacuation of uterine contents. Apropos of 32 cases at the Department of Gynecology, University Hospital Center, Nîmes, over 2 years (a retrospective study)].
    Marsollier C; Tailland ML; Courtieu C; Déchaud H; Marès P
    J Gynecol Obstet Biol Reprod (Paris); 1993; 22(4):399-404. PubMed ID: 8360440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pregnancy termination in the second trimester with vaginally administered dinoprostone followed by intravenous sulprostone, for the indication 'foetal congenital defects'; results of a retrospective study].
    Willems FE
    Ned Tijdschr Geneeskd; 2004 Aug; 148(33):1656-7; author reply 1657. PubMed ID: 15455517
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravenous sulprostone and uterine scarring based upon 22 cases of therapeutic abortion during 2nd and 3rd trimesters of pregnancy.
    Marpeau L; Percque M; Larue L; Guettier X; Jault T; Pigne A; Barrat J
    Eur J Obstet Gynecol Reprod Biol; 1993 Jul; 50(2):105-8. PubMed ID: 8405637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of sulprostone in the evacuation of molar pregnancies].
    Pinet C; Colau JC
    Rev Fr Gynecol Obstet; 1991 Jan; 86(1):53-5. PubMed ID: 2068488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of sulprostone for induction of preoperative cervical dilation or uterine evacuation: a comparison among the effects of different treatment schedules.
    Fruzzetti F; Melis GB; Strigini F; Vettori C; Ricci C; Fioretti P
    Obstet Gynecol; 1988 Nov; 72(5):704-8. PubMed ID: 3173921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of preinduction by mifepristone on therapeutic abortions of the second and third trimesters induced by intravenous sulprostone].
    D'Ercole C; Blanc B; Boubli L; Bautrant E; Nadal F; Eyraud B
    Rev Fr Gynecol Obstet; 1992 May; 87(5):277-80. PubMed ID: 1626173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Place of the sulprostone in therapeutic interruptions of the pregnancy].
    Khemiri B; Ben Slama A; Hsini A; Bedis Chennoufi M; Sfar E; Chelli H; Bouchnak M; Maghrebi H
    Tunis Med; 2007 May; 85(5):405-8. PubMed ID: 17657928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Termination of normal and pathological pregnancy with Sulprostone.
    Fischer Z; Chwalisz K; Michałkiewicz W
    Acta Chir Hung; 1986; 27(3):151-6. PubMed ID: 3825407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mifepristone and misoprostol versus Dilapan and sulprostone for second trimester termination of pregnancy.
    Jansen NE; Pasker-De Jong PC; Zondervan HA
    J Matern Fetal Neonatal Med; 2008 Nov; 21(11):847-51. PubMed ID: 18979392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of nalador for pregnancy termination in the second trimester].
    Bieńkiewicz A; Suzin J; Welfel J
    Ginekol Pol; 1993 Jan; 64(1):19-24. PubMed ID: 8359717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Termination of pregnancy and evacuation of the uterine contents in the second trimester. Use of a prostaglandin E2 analog: sulprostone].
    Barrat J; Cabrol D; Chouraqui A; Crépin G; Dumez Y; Hacker R; Henrion R; Magnin G; Soutoul JH; Sureau C
    J Gynecol Obstet Biol Reprod (Paris); 1987; 16(1):93-9. PubMed ID: 3584870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low dose sulprostone for termination of second and third trimester pregnancies.
    de Boer MA; van Gemund N; Scherjon SA; Kanhai HH
    Eur J Obstet Gynecol Reprod Biol; 2001 Dec; 99(2):244-8. PubMed ID: 11788180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of pregnancy termination for foetal congenital or chromosomal disorders or intrauterine foetal death by oral mifepristone and/or intravaginal misoprostol; results of a retrospective study].
    Verhulsdonk MT; Papatsonis DN; Heydanus R
    Ned Tijdschr Geneeskd; 2007 Apr; 151(14):815-20. PubMed ID: 17469323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of sulprostone in abortion induced during the first pregnancy trimester in women with previous cesarean section].
    Giannone R; Bernardi F; Ferrari E; Poli M
    Minerva Ginecol; 1990 Sep; 42(9):357-8. PubMed ID: 2284043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pregnancy termination in the second trimester with vaginally administered dinoprostone followed by intravenous sulprostone, for the indication 'foetal congenital defects'; results of a retrospective study].
    Stoutjesdijk JA; Alsma J; Wildschut HI
    Ned Tijdschr Geneeskd; 2004 Jun; 148(26):1293-6. PubMed ID: 15279214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical management for termination of second and third trimester pregnancies: a comparison of strategies.
    De Heus R; Graziosi GC; Christiaens GC; Bruinse HW; Mol BW
    Eur J Obstet Gynecol Reprod Biol; 2004 Sep; 116(1):16-21. PubMed ID: 15294361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of uterine evacuation following early medical abortion with mifepristone and misoprostol.
    Reeves MF; Monmaney JA; Creinin MD
    Contraception; 2016 Feb; 93(2):119-25. PubMed ID: 26285178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voluntary interruption of pregnancy with mifepristone (RU 486) and a prostaglandin analogue. A large-scale French experience.
    Silvestre L; Dubois C; Renault M; Rezvani Y; Baulieu EE; Ulmann A
    N Engl J Med; 1990 Mar; 322(10):645-8. PubMed ID: 2304490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind randomized controlled trial of mifepristone or placebo before buccal misoprostol for abortion at 14-21 weeks of pregnancy.
    Dabash R; Chelli H; Hajri S; Shochet T; Raghavan S; Winikoff B
    Int J Gynaecol Obstet; 2015 Jul; 130(1):40-4. PubMed ID: 25896965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Termination of pregnancy in the 2nd trimester: mifepriston/misoprostol preferable to sulprostone].
    Ebbers S; Creemers JW; Lotgering FK
    Ned Tijdschr Geneeskd; 2009; 153():A138. PubMed ID: 19930731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.